Ensuring that the right patients get the right treatments at the right time

Value Communications

vcimage2Identification of the added value of a product and its perceived positioning in the marketplace, and communication of this information to payers and decision makers is a prerequisite for ensuring optimal market access conditions. Mapi can develop your value proposition and support your market access campaign through our complete range of offerings in Value Communications:

Value Message Development
Targeted statements conveying the benefits of the product with supporting evidence.

Global Value Dossiers
Comprehensively communicates the evidence on how the product addresses the unmet need, and ensures consistency of messaging and communication internally between global and country affiliates.

Local Value Argumentation Dossiers
Communicates the value of the product tailored to the needs of the local market.

HTA National or Parallel Scientific Advice
Support the product development process and provide validation of your market access strategy.

Payer Advisory Boards and Briefing Materials
Gain insight into your product and recognize its possibilities and challenges.

HTA submissions
Complete all aspects of evidence generation and submission dossier preparation to achieve optimal outcomes of HTA appraisal.

Provide clear and concise dissemination of the evidence to target audiences.

Our in-house team of experienced medical writers, health economists and systematic reviewers enable us to provide you with the complete package of services above.



"Very satisfied with the high quality of the publications
developed by the Mapi team for our company."

− Value Communications client

"I was very impressed with your team's ability to deliver a very
well-structured and easy-to-read final report and draft manuscript. It can be very difficult to find a group that is well-versed both in study methodology and communication of results! Your team's strong writing skills have reduced the timelines of our manuscript development substantially!"

− Associate Director, Health Economics and Outcomes Research - Forest Research Institute

Request a consultation with an RWS&A expert